reglab/housing_qa huggingface dataset:
CA Health & Safety Code § 1626 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 7 - Blood Donations|Section 1626.

1626.  (a)  Except as provided in subdivisions (b) and (c), it shall be unlawful, in any transfusion of blood, to use any blood that was obtained from a paid donor.(b)  Subdivision (a) shall not be applicable to any transfusion of blood that was obtained from a paid donor if the physician and surgeon performing the transfusion has determined, taking into consideration the condition of the patient who is the recipient of the transfusion, that other blood of a type compatible with the blood type of the patient cannot reasonably be obtained for the transfusion.(c)  Subdivision (a) shall not apply to blood platelets secured from paid donors through the hemapheresis process if all of the following requirements are satisfied:(1)  The blood platelets are ordered by a doctor holding a valid California physician’s and surgeon’s certificate.(2)  The blood platelets are secured from a single donor and are sufficient to constitute a complete platelet transfusion.(3)  The donor’s identification number is recorded on the platelet label and is kept in the records of the entity providing the blood platelets for a minimum of five years.(4)  The donor has been examined by a doctor holding a valid California physician’s and surgeon’s certificate, and a repeat donor is reexamined at least annually.(5)  The transfusion is performed in a general acute care hospital.(6)  The blood platelets are processed according to standards issued by the American Association of Blood Banks, pursuant to Section 1602.1.(7)  The donor and blood are tested in accordance with regulations issued by the State Department of Health Services.(8)  The entity providing the blood platelets is licensed by the State Department of Health Services.(9)  The information that the donor of the blood platelets was compensated is printed on the label in accordance with Section 1603.5.(10)  In all instances, a potential donor shall provide a blood sample, which shall be tested with the standard panel of blood tests required by the State Department of Health Services for all blood donations. The results of the testing shall be obtained, evaluated, and determined to be acceptable prior to allowing the potential donor to provide his or her first donation of platelets. In addition, all donors shall be required to schedule an appointment for platelet donation.(11)  Any entity that is not collecting blood platelets from paid donors on August 1, 2000, shall obtain written permission from the director prior to compensating any donor for blood platelets.(d)  Subdivision (c) shall become inoperative on January 1, 2003.(Amended by Stats. 2012, Ch. 728, Sec. 83. (SB 71) Effective January 1, 2013.)
CA Health & Safety Code § 1628 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 8 - Umbilical Cord Blood Program|Section 1628.

1628.  (a) The University of California may accept public and private funds for the purpose of implementing this article.(b) The Umbilical Cord Blood Collection Program Fund is hereby created in the State Treasury. Any fees collected pursuant to Section 103625 shall be deposited into the fund. Moneys in the fund shall be available, upon appropriation by the Legislature, for purposes of this article.(c) The fund may include additional federal, state, and private funds made available for purposes of the program, including, but not limited to, the fees collected for the fund pursuant to Section 103625, and, notwithstanding Section 16305.7 of the Government Code, any interest earned on moneys in the fund.(d) (1) Funds shall be appropriated for the purposes of this article to the extent the plan the University of California is requested to develop pursuant to subdivision (a) of Section 1627 and the implementation of the plan are consistent with the goals and intent of this article.(2) In the event that funds are not appropriated for the program as described in this article, it is the intent of the Legislature that the University of California shall not implement the program.(Amended by Stats. 2010, Ch. 529, Sec. 3. (AB 52) Effective September 29, 2010. Repealed as of January 1, 2023, pursuant to Section 1630.)
CA Health & Safety Code § 1629 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 8 - Umbilical Cord Blood Program|Section 1629.

1629.  In implementing the program, the department shall make every effort to avoid duplication or conflicts with existing and ongoing programs and to leverage existing resources.(Added by Stats. 2007, Ch. 516, Sec. 2. Effective January 1, 2008. Repealed as of January 1, 2023, pursuant to Section 1630.)
CA Health & Safety Code § 1629.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 8 - Umbilical Cord Blood Program|Section 1629.5.

1629.5.  (a) On or before January 1, 2022, if it elects to administer the Umbilical Cord Blood Collection Program, the University of California shall provide a report to the Assembly and Senate Committees on Health that addresses, at a minimum, all of the following:(1) The number of cord blood units collected and registered under the program, disaggregated by race and ethnicity.(2) The number of registered units transplanted as a result of the program, disaggregated by race and ethnicity.(3) The number of California residents receiving a transplant as a result of the program.(4) The number of units made available for research and a summary of key research findings as a result of the program.(5) Annual budget information on the program, including revenues, spending, and beginning- and end-of-year balances.(6) Budget information for each participating cord blood bank, including collection and storage costs and available revenues to cover those costs.(7) Fees charged by participating cord blood banks for collecting, storing, handling, and providing units, and a summary of how these fees were determined.(8) Nationwide data on cord blood units collected, registered, and transplanted, disaggregated by race and ethnicity.(9) A summary of available cell sources for a hematopoietic stem cell transplant and research on the ability of underrepresented groups to find a suitable match for a transplant.(10) Any other outcomes or data regarding the impact of the program.(b) The requirement for submitting a report imposed under subdivision (a) is inoperative on December 31, 2022, pursuant to Section 10231.5 of the Government Code.(Added by Stats. 2017, Ch. 38, Sec. 2. (AB 114) Effective July 10, 2017. Repealed as of January 1, 2023, pursuant to Section 1630.)
CA Health & Safety Code § 1630 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 8 - Umbilical Cord Blood Program|Section 1630.

1630.  This article shall remain in effect only until January 1, 2023, and as of that date is repealed, unless a later enacted statute, that is enacted before January 1, 2023, deletes or extends that date.(Amended by Stats. 2017, Ch. 38, Sec. 3. (AB 114) Effective July 10, 2017. Repealed as of January 1, 2023, by its own provisions. Note: Repeal affects Article 8, commencing with Section 1627.)
CA Health & Safety Code § 1635 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 1 - Definitions, Licensure, and Exceptions|Section 1635.

1635.  (a) “Department” means the State Department of Public Health.(b) “Donor” means an individual, living or deceased, from whom tissue is removed.(c) “Gamete bank” means a tissue bank that collects, processes, stores, or distributes sperm, oocytes, or embryos, including a facility that provides professional reproductive services, other than those facilities exempt from tissue bank licensure.(d) “Person” means an individual, corporation, business trust, estate trust, partnership, association, state or local government, or subdivision or agency thereof, or any other legal entity.(e) (1) “Tissue” means a human cell, group of cells, including the cornea, sclera, or vitreous humor and other segments of, or the whole eye, bones, skin, arteries, sperm, oocytes, embryos, blood, other fluids, and any other portion of a human body, but shall not include an organ when recovered for transplantation or research purposes.(2) For purposes of paragraph (1), “organ” means a human kidney, liver, heart, lung, pancreas, intestine (including the esophagus, stomach, small or large intestine, or any portion of the gastrointestinal tract), or vascularized composite allograft, and associated blood vessels recovered from an organ donor during the recovery of the organ.(f) “Tissue bank” means a place, establishment, or institution that collects, processes, stores, or distributes tissue for transplantation into human beings.(g) “Transplantation” means the act or process of transferring tissue, including by ingestion, from a donor to the body of the donor or another human being.(Amended by Stats. 2019, Ch. 539, Sec. 1. (AB 785) Effective January 1, 2020.)
CA Health & Safety Code § 1635.2 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 1 - Definitions, Licensure, and Exceptions|Section 1635.2.

1635.2.  The Legislature hereby declares its intent that the collection, processing, storage, or distribution of tissue for the purpose of transplantation, as regulated by this chapter, shall be deemed a service by those persons engaged in these activities. Therefore, the collection, processing, storage, or distribution of tissue for the purpose of transplantation, as regulated by this chapter, shall not be subject to the requirements of Division 2 (commencing with Section 2101) of the Commercial Code.(Added by Stats. 1991, Ch. 801, Sec. 2.)
CA Health & Safety Code § 1639 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 2 - Regulation of Tissue Banks|Section 1639.

1639.  (a)  The department may adopt rules and regulations governing the administration and enforcement of this chapter. (b)  Regulations adopted by the department may include minimum standards for the following: (1)  Safe preservation, transportation, storage, and handling of tissue acquired or used for transplantation. (2)  Testing of donors to determine compatibility when appropriate. (3)  Testing or assessment of donors to prevent the spread of disease through transplantation. (4)  Equipment. (5)  Methods. (6)  Personnel qualifications. (7)  Any other area concerning the operation or maintenance of a tissue bank, not inconsistent with this chapter, as may be necessary to carry out this chapter. (c)  The department shall report to the Legislature by January 1, 2004, on the status of the regulations developed pursuant to this section. (Amended by Stats. 2003, Ch. 464, Sec. 1. Effective January 1, 2004.)
CA Health & Safety Code § 1639.01 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 2 - Regulation of Tissue Banks|Section 1639.01.

1639.01.  (a)  Notwithstanding Section 1639, the state department shall adopt, on or before July 1, 2004, rules and regulations governing licensed tissue banks engaged in the collection of human musculoskeletal tissue, skin, and veins for transplantation in humans. The regulations shall be substantially based upon the criteria used by tissue bank trade associations in their respective accreditation processes including, but not limited to, those of the Eye Bank Association of America and the American Association of Tissue Banks, and the scientific and technical data submitted by individual tissue banks. (b)  Regulations adopted by the state department, pursuant to subdivision (a), shall include minimum standards for all of the following: (1)  Safe preservation, transportation, storage, and handling of tissue acquired or used for transplantation. (2)  Testing of donors to determine compatibility when appropriate. (3)  Testing or assessment of donors to prevent the spread of disease through transplantation. (4)  Equipment. (5)  Methods. (6)  Personnel qualifications. (7)  Any other area concerning the operation or maintenance of a tissue bank, not inconsistent with this chapter, as may be necessary to carry out this chapter. (c)  On or before July 1, 2003, the department shall report to the appropriate policy and fiscal committees of the Legislature regarding the status of the proposed regulations. (Added by Stats. 2002, Ch. 929, Sec. 1. Effective January 1, 2003.)
CA Health & Safety Code § 1639.1 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 2 - Regulation of Tissue Banks|Section 1639.1.

1639.1.  Any person desiring a license issued pursuant to Section 1639.3 shall file with the state department a verified application on forms prescribed by the state department containing all of the following:(a)  The name of the applicant for licensure. (b)  The street address of the tissue bank. If more than one street address is occupied by the tissue bank, all occupied street addresses shall be listed. (c)  Whether the applicant is an individual, partnership, unincorporated association, or corporation. (d)  Whether the applicant does business under a fictitious name, and, if so, the fictitious name and the name of the locality wherein any fictitious name permit is filed. (e)  If the applicant is a partnership, the names of all the members of the partnership, or unincorporated association, whether general or limited. (f)  If the applicant is a corporation, the name of the officers, directors, shareholders holding a 5 percent or more interest in the corporation, and any person, partnership, or corporation who or which has the responsibility to manage or conduct the day-to-day operation of the tissue bank. (g)  The type of tissue collected, processed, stored, or distributed by the tissue bank. (h)  The names, titles, and qualifications of the persons responsible for the collection, processing, storage, or distribution of tissue by the tissue bank. (i)  Any process utilized by the tissue bank to ensure safe preservation, transportation, storage, and handling, of tissue acquired or used by the tissue bank. (j)  Any process utilized by the tissue bank to determine if, when appropriate, donors have been tested to determine compatibility. (k)  Any process utilized by the tissue bank to determine if donors have been tested or assessed for the transmission of disease through transplantation. (Added by Stats. 1991, Ch. 801, Sec. 2.)
CA Health & Safety Code § 1639.2 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 2 - Regulation of Tissue Banks|Section 1639.2.

1639.2.  (a)  Each license issued pursuant to subdivision (a) of Section 1639.3 before July 1, 1992, shall expire July 1, 1993. Every other license issued pursuant to subdivision (a) of Section 1639.3 shall expire 12 months from the date of issuance. (b)  An application for renewal of a license issued pursuant to subdivision (a) of Section 1639.3 shall be filed with the state department not less than 30 days prior to its expiration date and shall be accompanied by the annual renewal fee required in Section 1639.5. Failure to make timely application or payment for renewal shall result by operation of law in expiration of the license on its expiration date. (c)  Upon application and payment of the required fee, a renewal license issued under subdivision (a) of Section 1639.3 shall be renewed for one- or two-year periods, at the option of the licensee, as long as the licensee has been found to be in substantial compliance with this chapter and the rules and regulations adopted under this chapter during the preceding license period. (d)   Any license issued pursuant to this chapter shall be forfeited by operation of law prior to its expiration date when one of the following occurs: (1)  The tissue bank is sold or otherwise transferred. (2)  The license is surrendered to the state department. (Added by Stats. 1991, Ch. 801, Sec. 2.)
CA Health & Safety Code § 1639.3 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 2 - Regulation of Tissue Banks|Section 1639.3.

1639.3.  (a)  Upon the filing of the verified application for licensure required by Section 1639.1, payment of the application fee in the amount required in Section 1639.5, and full compliance with this chapter and the rules and regulations adopted by the state department, the state department shall issue a license to operate a tissue bank to the applicant. (b)  If the state department finds that the applicant is not in compliance with this chapter or the rules or regulations adopted under this chapter, or if it finds that the applicant has acted in a manner which would justify the revocation or suspension of a tissue bank license as described in Section 1643, the license shall be denied. (c)  The state department may, prior to a determination under subdivision (a) that the applicant is in full compliance, but after the filing of a complete and verified application and payment of the application fee, issue a provisional license to operate a tissue bank to the applicant. The provisional license shall remain in effect until a license is either granted under subdivision (a) or denied under subdivision (b). If this period is longer than a year from the date of filing the application for licensure, the applicant shall pay an additional annual fee of nine hundred fifty dollars ($950) in order for the provisional license to remain in effect for an additional one-year period. Failure to pay the additional annual fee shall result, by operation of law, in automatic expiration of the provisional license one year from the date of its original issuance. If the provisional license does so expire, the applicant may not continue to operate a tissue bank pending the department’s determination of whether a license shall be granted or denied.(Added by Stats. 1991, Ch. 801, Sec. 2.)
CA Health & Safety Code § 1639.35 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 2 - Regulation of Tissue Banks|Section 1639.35.

1639.35.  Any person, when submitting an application for a license, including the renewal thereof, pursuant to this chapter, shall also submit, with the application, a copy of the applicant’s standard informed consent form required pursuant to Section 7158.3.(Added by Stats. 2003, Ch. 464, Sec. 2. Effective January 1, 2004.)
CA Health & Safety Code § 1639.4 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 2 - Regulation of Tissue Banks|Section 1639.4.

1639.4.  Immediately upon the denial of any application for a license, the state department shall notify the applicant in writing. Within 20 days after the state department mails the notice, the applicant may present a written petition for a hearing to the state department. Upon receipt by the state department of the petition in proper form, the petition shall be set for hearing. The proceedings shall be conducted in accordance with Section 100171.(Amended by Stats. 1997, Ch. 220, Sec. 20. Effective August 4, 1997.)
CA Health & Safety Code § 1639.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 2 - Regulation of Tissue Banks|Section 1639.5.

1639.5.  (a)  The application and annual renewal fee for a tissue bank license shall be nine hundred fifty dollars ($950). Upon application for renewal of a license issued pursuant to subdivision (a) of Section 1639.3, the amount of the annual renewal fee required shall be determined by the period of time for which renewal is sought, which shall be either a one- or two-year period. The amount due shall be the amount prorated to the length of time the renewal is sought, based on the annual nine hundred fifty dollar ($950) fee. (b)  Notwithstanding subdivision (a), no license fee shall be required for any tissue bank operated by the state or any state agency, or by a district, city, county, or city and county, or any subdivision or agency thereof, or by a “mothers’ milk bank,” as defined in subdivision (b) of Section 14132.34 of the Welfare and Institutions Code, that has applied for tissue bank licensure prior to January 1, 1995. (Amended by Stats. 1994, Ch. 639, Sec. 1. Effective January 1, 1995.)
CA Health & Safety Code § 1639.55 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4.1 - Tissue Banks|ARTICLE 2 - Regulation of Tissue Banks|Section 1639.55.

1639.55.  (a)  There is hereby established in the State Treasury the Tissue Bank License Fund. Notwithstanding any other provision of law, if, at the end of any fiscal year, the unencumbered balance in any account in the Tissue Bank License Fund exceeds 110 percent of the amount appropriated from the account for the following fiscal year, the state department shall reduce the application and annual renewal fees which are deposited into the account. The amount of the reduction shall be sufficient to reduce the unencumbered balance in the account at the end of the following fiscal year to less than 110 percent of the amount appropriated in that fiscal year. The adjustment of fees pursuant to this section shall not be subject to the requirements of Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. (b)  The state department shall receive and account for all money received pursuant to this chapter and shall deposit it with the Treasurer who shall keep the money in the Tissue Bank License Fund. (c)  Moneys deposited to the credit of the Tissue Bank License Fund which are appropriated in the Budget Act or any other appropriation act for support of or expenditure by the state department shall be used by the state department to administer this chapter. (d)  Upon the request of the State Director of Health Services, the Director of Finance may make a loan to the Tissue Bank License Fund from funds appropriated from the General Fund for that purpose. The amount of any such loan shall be approved by the Director of Finance and be repaid under those terms and conditions as prescribed by the Director of Finance, but shall, in any event, be repaid not later than June 30, 1995. (Added by Stats. 1991, Ch. 801, Sec. 2.)